Loading…
MINIMS TROPICAMIDE is a brand name for Tropicamide, supplied as a drops. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: AND CLINICAL USE ........................................................................ 3 CONTRAINDICATIONS .............................................................................................. 3 WARNINGS AND PRECAUTIONS ............................................................................ 4 ADVERSE…
Verbatim from this product's HC label. Tap a section to expand.
General Use great caution when anticholinergic drugs, such as MINIMS TROPICAMIDE, are administered in patients with any of the following conditions: Tachycardia or heart failure, stenosis of the gastrointestinal tract, urinary obstruction, myasthenia gravis, hyperthyroidism, acute pulmonary oedema, preeclampsia, Down's syndrome, or rhinitis sicca.
Ophthalmologic MINIMS TROPICAMIDE may cause increased intraocular pressure (IOP). The possibility of undiagnosed glaucoma should be considered in some patients, such as elderly patients. IOP and an estimation of the depth of the angle of the anterior chamber should be determined prior to initiation of therapy.
Patients must be instructed to remove contact lenses prior to the application of MINIMS TROPICAMIDE and wait at least 15 minutes before reinsertion. To reduce systemic absorption, the lacrimal sac should be compressed at the medial canthus by digital pressure for at least two minutes after instillation of the drop.
Use with caution in an inflamed eye as the hyperaemia greatly increases the rate of systemic absorption through the conjunctiva. There is a possibility that tropicamide may decrease lacrimation and therefore induce false positive Schirmer test results.
Therefore, Schirmer’s test should be performed preferably before administration of tropicamide. MINIMS TROPICAMIDE may cause drowsiness, blurred vision and sensitivity to light. Patients should be warned not to drive or engage in other hazardous activities unless vision is clear.
MINIMS TROPICAMIDE is for topical ophthalmic use only. It should not be used for intravenous injection. Psychiatric Tropicamide-induced psychotic reactions and behavioural changes may occur in patients with increased susceptibility to anticholinergic drugs.
MINIMS TROPICAMIDE should only be for topical instillation in the eye. It should not be used for injection as cases of death have been reported following intravenous injection of this drug. Use with extreme caution in children. PrMINIMS® TROPICAMIDE Product Monograph Page 5 of 10 Special Populations Pregnant Women There are no or limited amount of data from the use of tropicamide in pregnant women.
MINIMS TROPICAMIDE is not recommended during pregnancy. Nursing Women It is unknown whether tropicamide or its metabolites are excreted in human milk. A risk to the newborns/infants cannot be excluded, therefore, a decision must be made whether to discontinue breastfeeding or discontinue MINIMS TROPICAMIDE therapy taking into account the potential benefit to the mother and potential risk to the infant.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Tropicamide in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
, < 3 months of age). MINIMS TROPICAMIDE should only be for topical instillation in the eye. It should not be used for injection as cases of death have been reported following intravenous injection of this drug. Tropicamide may cause central nervous system disturbances, which may be dangerous in infants and children.
Vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drug. Excessive use in children may produce systemic toxic symptoms. MINIMS TROPICAMIDE should only be used with extreme caution in infants, small or premature children, or children with Down syndrome, spastic paralysis or brain damage.
Parents should be warned of the oral toxicity of MINIMS TROPICAMIDE for children and advised to wash their own hands and their child’s hands following administration. ADVERSE REACTIONS Adverse events observed following use of MINIMS TROPICAMIDE include the following: hypersensitivity, rash, dizziness, staggering, headache, eye irritation, eye pain, ocular hyperemia, photophobia, vision blurred, nausea, hypotension, syncope and drug effect prolonged (mydriasis).
In addition, cycloplegic drugs may increase IOP and can precipitate angle-closure glaucoma in predisposed patients. Psychotic reactions and behavioural disturbances have been reported with this class of drug, especially in children.
Other toxic manifestations of anticholinergic drugs include: flushing of the skin, pallor, dryness of mucous membranes, bradycardia followed by tachycardia with palpitations and arrhythmia, decreased secretion in sweat glands and dryness of the mouth, diminished gastrointestinal motility, vomiting and constipation, urinary retention and decreased nasal, bronchial and PrMINIMS® TROPICAMIDE Product Monograph Page 6 of 10 lachrymal secretions, contact dermatitis, and flare-up of myasthenia gravis.
Cardiorespiratory collapse have been reported in children. DRUG INTERACTIONS The effects of tropicamide may be enhanced by concomitant use of other drugs having antimuscarinic properties, such as amantadine, some antihistamines, phenothiazine antipsychotics and tricyclic antidepressants.
Tropicamide may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors. DOSAGE AND ADMINISTRATION MINIMS TROPICAMIDE is for topical ophthalmic use only. Instill the content of 1 unit topically in the eye(s).
The lacrimal sac should be compressed at the medial canthus by digital pressure for at least two minutes after instillation of the drop. If more than one topical ophthalmic medicinal product is being used, the medicines must be administered at least 5 minutes apart.
Eye ointments should be administered last. OVERDOSAGE An ocular overdose of MINIMS TROPICAMIDE can be flushed from the eye(s) with lukewarm water. Systemic toxicity may occur following topical use, particularly in children. It is manifested by flushing and dryness of the skin (a rash may be present in children), blurred vision, a rapid and irregular pulse, fever, abdominal distension in infants, convulsions and hallucinations, and the loss of neuromuscular coordination.
Treatment is symptomatic and supportive. In infants and small children, the body surface must be kept moist. For management of a suspected drug overdose, contact your regional Poison Control […]